Fulcrum Therapeutics, INC. (FULC) SEC Filings — 2024
28 SEC filings for Fulcrum Therapeutics, INC. (FULC) in 2024.
Filings
- Fulcrum Therapeutics Terminates Material Agreement — 8-K · Dec 23, 2024
- Fulcrum Therapeutics, INC. SC 13G Filing — SC 13G · Dec 6, 2024
- Fulcrum Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Fulcrum Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Fulcrum Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
- Fulcrum Therapeutics Announces Board and Compensation Changes — 8-K · Nov 12, 2024
- Fulcrum Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Fulcrum Therapeutics, INC. SC 13G Filing — SC 13G · Nov 8, 2024
- Fulcrum Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Fulcrum Therapeutics, INC. SC 13G Filing — SC 13G · Oct 21, 2024
- Fulcrum Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Oct 7, 2024
- Fulcrum Therapeutics Files 8-K — 8-K · Sep 24, 2024
- Fulcrum Therapeutics, INC. SC 13G Filing — SC 13G · Sep 20, 2024
- Fulcrum Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Sep 16, 2024
- Fulcrum Therapeutics Files 8-K — 8-K · Sep 12, 2024
- Fulcrum Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Aug 23, 2024
- Fulcrum Therapeutics Sells $100M in Stock — 8-K · Aug 22, 2024
- Fulcrum Therapeutics Files Q2 2024 10-Q — 10-Q · Jul 31, 2024
- Fulcrum Therapeutics Appoints New CMO, Elects Directors — 8-K · Jun 17, 2024
- Fulcrum Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- Fulcrum Therapeutics Announces 2024 Annual Meeting of Stockholders on June 17 — DEF 14A · Apr 19, 2024
- Fulcrum Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 27, 2024
- Fulcrum Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Fulcrum Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Fulcrum Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Fulcrum Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- FMR LLC & Abigail Johnson Maintain 9.195% Stake in Fulcrum Therapeutics — SC 13G/A · Feb 9, 2024
- Adage Capital Partners Cuts Fulcrum Therapeutics Stake to 1.9% — SC 13G/A · Feb 7, 2024